[Retracted] Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin
Affiliations: Department of Orthopedics, The Second Hospital of Jilin university, Nanguan, Changchun, Jilin 130042, P.R. China
- Published online on: October 29, 2021 https://doi.org/10.3892/or.2021.8213
- Article Number: 2
Copyright : © Qu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
This article is mentioned in:
Oncol Rep 33: [Related article:] 1177-1184, 2015; DOI: 10.3892/or.2014.3698
Following the publication of this paper, it was drawn to the Editors attention by a concerned reader that the western blotting data featured in Figs. 2B and 4D, the flow cytometric data in Fig. 4A and the tumour images shown in Fig. 6A were strikingly similar to data appearing in different form in other articles at different research institutes. Owing to the fact that the contentious data in the above article were already under consideration for publication, or had already been published, elsewhere prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused.